EP1137771A2
(en)
*
|
1998-11-10 |
2001-10-04 |
The Board Of Regents, The University Of Texas System |
Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
|
JP2001149081A
(ja)
*
|
1999-11-29 |
2001-06-05 |
Cyclex Co Ltd |
脱アセチル化酵素の活性測定方法、並びにこれら酵素の阻害剤もしくは促進剤のスクリーニング方法
|
PE20020354A1
(es)
*
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
US6706686B2
(en)
*
|
2001-09-27 |
2004-03-16 |
The Regents Of The University Of Colorado |
Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
US20040077083A1
(en)
*
|
2002-10-17 |
2004-04-22 |
Isis Pharmaceuticals Inc. |
Antisense modulation of histone deacetylase 4 expression
|
US7250514B1
(en)
|
2002-10-21 |
2007-07-31 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
US20070104688A1
(en)
|
2003-02-13 |
2007-05-10 |
City Of Hope |
Small interfering RNA mediated transcriptional gene silencing in mammalian cells
|
US20040171118A1
(en)
*
|
2003-02-13 |
2004-09-02 |
City Of Hope |
Methods for directing DNA methylation in mammalian cells using homologous short double stranded RNAs
|
US7375228B2
(en)
*
|
2003-03-17 |
2008-05-20 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
CA2526423A1
(en)
*
|
2003-05-21 |
2004-12-29 |
Board Of Regents, The University Of Texas System |
Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure
|
CN1964714B
(zh)
*
|
2003-08-29 |
2011-09-28 |
Hdac默克研究有限责任公司 |
辛二酰苯胺异羟肟酸和吉西他滨在制备用于治疗癌症的药物中的用途
|
WO2005066151A2
(en)
*
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
US20050159470A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
CA2555632A1
(en)
*
|
2004-02-02 |
2005-08-18 |
Myogen, Inc. |
Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure
|
US20050197336A1
(en)
*
|
2004-03-08 |
2005-09-08 |
Miikana Therapeutics Corporation |
Inhibitors of histone deacetylase
|
US7345043B2
(en)
*
|
2004-04-01 |
2008-03-18 |
Miikana Therapeutics |
Inhibitors of histone deacetylase
|
CA2561954A1
(en)
*
|
2004-04-05 |
2005-10-20 |
Myogen, Inc. |
Inhibition of nuclear export as a treatment for cardiac hypertrophy and heart failure
|
JP5074921B2
(ja)
|
2004-04-07 |
2012-11-14 |
アキシオジェネシス エージー |
非侵襲性生体外機能組織検定システム
|
ES2354997T3
(es)
|
2004-05-11 |
2011-03-21 |
Axiogenesis Ag |
Ensayo para el descubrimiento de fármacos basado en células diferenciadas in vitro.
|
FI20040675A0
(fi)
*
|
2004-05-12 |
2004-05-12 |
Orion Corp |
Menetelmä sydämen hypertrofian hoitoon ja estoon
|
US20060110390A1
(en)
*
|
2004-08-25 |
2006-05-25 |
Myogen, Inc. |
Inhibition of Ku as a treatment for cardiovascular diseases
|
WO2006060382A2
(en)
*
|
2004-11-30 |
2006-06-08 |
Trustees Of The University Of Pennsylvania |
Use of hdac and/or dnmt inhibitors for treatment of ischemic injury
|
JP2008524246A
(ja)
*
|
2004-12-16 |
2008-07-10 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
US7772245B2
(en)
|
2005-02-14 |
2010-08-10 |
Miikana Therapeutics, Inc. |
Inhibitors of histone deacetylase
|
US20100087328A1
(en)
*
|
2005-03-01 |
2010-04-08 |
The Regents Of The University Of Michigan |
Brm expression and related diagnostics
|
US7604939B2
(en)
*
|
2005-03-01 |
2009-10-20 |
The Regents Of The University Of Michigan |
Methods of identifying active BRM expression-promoting HDAC inhibitors
|
JP2008540574A
(ja)
*
|
2005-05-11 |
2008-11-20 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
WO2007011757A1
(en)
*
|
2005-07-14 |
2007-01-25 |
Myogen, Inc. |
Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart
|
CN101263121A
(zh)
*
|
2005-07-14 |
2008-09-10 |
塔克达圣地亚哥公司 |
组蛋白脱乙酰基酶抑制剂
|
CN101282718A
(zh)
*
|
2005-08-10 |
2008-10-08 |
诺瓦提斯公司 |
脱乙酰酶抑制剂的使用方法
|
EP1965824A4
(en)
*
|
2005-11-18 |
2011-10-19 |
Gloucester Pharmaceuticals Inc |
METABOLITENE DERIVATIVES OF HDAC INHIBITOR FK228
|
EP1962888A2
(en)
*
|
2005-11-18 |
2008-09-03 |
Myogen, Inc. |
Uses for camkii and hdacs in the treatment of heart conditions
|
US20070207950A1
(en)
*
|
2005-12-21 |
2007-09-06 |
Duke University |
Methods and compositions for regulating HDAC6 activity
|
JP2009525955A
(ja)
*
|
2006-01-13 |
2009-07-16 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
CA2647359A1
(en)
*
|
2006-03-29 |
2007-11-08 |
Edward Via Virginia College Of Osteopathic Medicine |
Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites
|
AU2007234380A1
(en)
*
|
2006-04-06 |
2007-10-11 |
Novartis Ag |
Combination of organic compounds
|
EP2010476A4
(en)
|
2006-04-13 |
2011-01-26 |
Univ Wake Forest Health Sciences |
NITROXYL DISPENSERS FROM C-NITROSO COMPOUNDS
|
US20100137239A1
(en)
*
|
2006-04-24 |
2010-06-03 |
Gloucester Pharmaceuticals |
Gemcitabine combination therapy
|
WO2007146730A2
(en)
|
2006-06-08 |
2007-12-21 |
Gloucester Pharmaceuticals |
Deacetylase inhibitor therapy
|
CN101801994A
(zh)
*
|
2006-12-29 |
2010-08-11 |
格洛斯特制药公司 |
制备Romidepsin
|
BRPI0720734A2
(pt)
*
|
2006-12-29 |
2014-01-07 |
Gloucester Pharmaceuticals Inc |
Preparação da romidepsina
|
WO2008140708A1
(en)
*
|
2007-05-09 |
2008-11-20 |
The Trustees Of The University Of Pennsylvania |
Use of hdac inhibitors for treatment of cardiac rhythm disorders
|
US7737175B2
(en)
*
|
2007-06-01 |
2010-06-15 |
Duke University |
Methods and compositions for regulating HDAC4 activity
|
WO2009048540A1
(en)
*
|
2007-10-05 |
2009-04-16 |
U.S. Department Of Veterans Affairs Office Of General Counsel - Psg Iv (024) |
Method and composition for treating heart failure
|
WO2009089598A2
(en)
*
|
2008-01-18 |
2009-07-23 |
Katholieke Universiteit Leuven |
Msmb-gene methylation based diagnosis, staging and prognosis of prostate cancer
|
US20100212036A1
(en)
*
|
2008-09-30 |
2010-08-19 |
Olson Eric N |
Selective inhibition of histone deacetylases 1 and 2 as a treatment for cardiac hypertrophy
|
WO2011032088A1
(en)
|
2009-09-11 |
2011-03-17 |
Arca Biopharma, Inc. |
Polymorphisms in the pde3a gene
|
US20120190817A2
(en)
|
2010-07-12 |
2012-07-26 |
Celgene Corporation |
Romidepsin solid forms and uses thereof
|
US8859502B2
(en)
|
2010-09-13 |
2014-10-14 |
Celgene Corporation |
Therapy for MLL-rearranged leukemia
|
EP2627316B1
(en)
|
2010-10-13 |
2019-03-27 |
Medivir AB |
Pharmaceutical formulation for histone deacetylase inhibitors
|
AU2013202506B2
(en)
|
2012-09-07 |
2015-06-18 |
Celgene Corporation |
Resistance biomarkers for hdac inhibitors
|
AU2013202507B9
(en)
|
2012-11-14 |
2015-08-13 |
Celgene Corporation |
Inhibition of drug resistant cancer cells
|
NZ630311A
(en)
|
2013-12-27 |
2016-03-31 |
Celgene Corp |
Romidepsin formulations and uses thereof
|
TWI808055B
(zh)
|
2016-05-11 |
2023-07-11 |
美商滬亞生物國際有限公司 |
Hdac 抑制劑與 pd-1 抑制劑之組合治療
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Hdac抑制劑與pd-l1抑制劑之組合治療
|
CN114980887A
(zh)
|
2019-12-20 |
2022-08-30 |
特纳亚治疗股份有限公司 |
氟代烷基-噁二唑及其用途
|